CYP2C19 Genotype-Dependent Pharmacokinetic Drug Interaction Between Voriconazole and Ritonavir-Boosted Atazanavir in Healthy Subjects.
about
Pharmacogenomics of Drug Metabolizing Enzymes and Transporters: Relevance to Precision MedicineDrug-drug interactions between triazole antifungal agents used to treat invasive aspergillosis and immunosuppressants metabolized by cytochrome P450 3A4.Pharmacogenomics of triazole antifungal agents: implications for safety, tolerability and efficacy.Notable Drug-Drug Interaction Between Etizolam and Itraconazole in Poor Metabolizers of Cytochrome P450 2C19.PharmGKB summary: atazanavir pathway, pharmacokinetics/pharmacodynamics
P2860
CYP2C19 Genotype-Dependent Pharmacokinetic Drug Interaction Between Voriconazole and Ritonavir-Boosted Atazanavir in Healthy Subjects.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
CYP2C19 Genotype-Dependent Pha ...... tazanavir in Healthy Subjects.
@en
CYP2C19 Genotype-Dependent Pha ...... tazanavir in Healthy Subjects.
@nl
type
label
CYP2C19 Genotype-Dependent Pha ...... tazanavir in Healthy Subjects.
@en
CYP2C19 Genotype-Dependent Pha ...... tazanavir in Healthy Subjects.
@nl
prefLabel
CYP2C19 Genotype-Dependent Pha ...... tazanavir in Healthy Subjects.
@en
CYP2C19 Genotype-Dependent Pha ...... tazanavir in Healthy Subjects.
@nl
P2093
P2860
P356
P1476
CYP2C19 Genotype-Dependent Pha ...... tazanavir in Healthy Subjects.
@en
P2093
Angela Colbers
Blisse Vakkalagadda
David M Burger
Ellen Chung
Jonathan Uy
Karen Sims
Matthew W Hruska
Richard J Bertz
Roger J Brüggemann
P2860
P304
P356
10.1002/JCPH.798
P577
2016-07-19T00:00:00Z